ArticleSurgical endoscopy2026
Endoscopic classification of Meckel's diverticulum in adults: a multicenter retrospective study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundMeckel's diverticulum (MD) is the most common congenital gastrointestinal malformation. Balloon-assisted enteroscopy (BAE) permits direct visualization in adults, but no standardized endoscopic classification exists. We developed an endoscopic framework for adult MD and evaluated its clinical utility and association with disease severity.
methodsIn this multicenter retrospective study, we enrolled 226 symptomatic adults with BAE-diagnosed MD at three tertiary centers from May 2007 to May 2024. Based on morphology and mucosal characteristics, MD was assigned to three primary categories: Type S, an endoscopically quiescent smooth mucosa pattern; Type A, abnormal mucosa or high-risk structural features; and Type U, lesions that could not be adequately characterized. Inverted MD was recorded as Type I, a morphological subtype within the Type A spectrum. Reproducibility of the core Type S-versus-Type A distinction was assessed using Fleiss' and Cohen's kappa statistics among six external experts and the lead author. Multivariable logistic regression evaluated factors associated with severe disease presentation.
resultsThe Type A spectrum included 159 patients, comprising 155 non-inverted Type A cases and 4 Type I cases. Type S was identified in 64 patients, and Type U in 3 patients. Interobserver agreement for the core Type S-versus-Type A distinction was substantial (Fleiss' kappa = 0.7936). Multivariate analysis showed that Type A (including Type I) was the only factor independently associated with severe disease presentation (OR: 5.550; 95% CI 2.693-11.439; P < 0.001).
conclusionThe A-S framework provides a concise morphological approach for symptomatic adults with BAE-diagnosed MD. It distinguishes lesions for which surgical consultation and resection should be considered from those generally suitable for conservative management, while Type U warrants further evaluation. Prospective external validation is required.
Indexed as
Identifiers
42758177What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.